← back to search

Sebastian Newrzela

Institut zur Förderung von Bildung und Integration ·
🔎 Find collaborators in Oncology · Genetics →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Oncology · Genetics
Research interest
Research interests include CAR-T cell therapy research, Lymphoma Diagnosis and Treatment, Virus-based gene therapy research, and Immune Cell Function and Interaction.
h-index
20
citations
1,342
works
42
NIH funding
primary concept
email

Recent publications

Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC
Nature 2026cited by 4position: middledoi
88MO T-cell responses induced by an individualized neoantigen specific immune therapy in post (neo)adjuvant patients with triple negative breast cancer
Annals of Oncology 2020cited by 34position: middledoi
Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL
Nature Communications 2018cited by 105position: middledoi
Ectopic expression of transcription factor BATF3 induces B-cell lymphomas in a murine B-cell transplantation model
Oncotarget 2018cited by 10position: lastdoi
Re-activation of mitochondrial apoptosis inhibits T-cell lymphoma survival and treatment resistance
Leukemia 2016cited by 32position: middledoi
Highly recurrent mutations of SGK1, DUSP2 and JUNB in nodular lymphocyte predominant Hodgkin lymphoma
Leukemia 2015cited by 100position: middledoi
On the origin of giant cells in Hodgkin lymphoma
Communicative & Integrative Biology 2014cited by 15position: lastdoi
Nodular Lymphocyte Predominant Hodgkin Lymphoma and T Cell/Histiocyte Rich Large B Cell Lymphoma - Endpoints of a Spectrum of One Disease?
PLoS ONE 2013cited by 114position: middledoi
Incomplete cytokinesis and re-fusion of small mononucleated Hodgkin cells lead to giant multinucleated Reed–Sternberg cells
Proceedings of the National Academy of Sciences 2013cited by 85position: middledoi
Overexpression of the anti-apoptotic protein AVEN contributes to increased malignancy in hematopoietic neoplasms
Oncogene 2012cited by 20position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Benjamin Rengstl · BioNTech (Germany)5 papers (2013–2018)Sylvia Hartmann · Goethe University Frankfurt4 papers (2013–2018)Ralf Küppers · Heinrich Heine University Düsseldorf4 papers (2013–2018)Michael A. Rieger · Fraunhofer Institute for Translational Medicine and Pharmacology3 papers (2012–2014)Christian Weiser · Goethe University Frankfurt3 papers (2013–2018)Martin‐Leo Hansmann · Goethe University Frankfurt3 papers (2013–2018)Claudia Döring · Goethe University Frankfurt3 papers (2013–2018)Stefanie Bolte · BioNTech (Germany)2 papers (2020–2026) · 2 papers (2020–2026)Tana Omokoko · BioNTech (Germany)2 papers (2020–2026)Sebastian Attig · Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz2 papers (2020–2026)Isabel Vogler · BioNTech (Germany)2 papers (2020–2026)Evelyna Derhovanessian · BioNTech (Germany)2 papers (2020–2026)M-L Hansmann · Goethe University Frankfurt2 papers (2015–2016)Mathias Heikenwälder · German Cancer Research Center1 papers (2016–2016)Nicole Müller · Technical University of Munich1 papers (2016–2016)Ulrich Keller · SLK-Kliniken Heilbronn1 papers (2016–2016)Randy D. Gascoyne · BC Cancer Agency1 papers (2013–2013)Anna Lollies · University of California, Davis1 papers (2015–2015) · 1 papers (2016–2016)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Oncology · Genetics →